FIELD: medicine pharmaceutics.SUBSTANCE: present invention refers to a pharmaceutical composition of such an active agent as sucralfate for treating disorders e.g. gastric ulcers duodenal ulcers acute gastritis symptomatic chronic gastritis gastropathy caused by the intake of anti-inflammatory agents gastroesophageal reflux disease characterised by the fact that is contains one or more phospholipids.EFFECT: invention refers to using phospholipids in a combination with the above active agents whe...